BOSTON, May 30, 2025 — Haemonetics Corporation (NYSE: HAE) has announced that its President and CEO, Chris Simon, will be engaging in a discussion with investors at the Goldman Sachs 46th Annual Global Healthcare Conference. The event is scheduled for Monday, June 9, 2025, at 8:40 a.m. ET.

A live audio webcast of the discussion will be available to the public through the Investor Relations section of Haemonetics’ website, or by using the following link:

A recorded replay of the webcast will be available on Haemonetics’ Investor Relations website starting 12 hours after the event and for a period of 90 days.

ABOUT HAEMONETICS

Haemonetics is a global medical technology company focused on improving healthcare quality, effectiveness, and efficiency. We offer innovative solutions for critical medical needs, including hospital technologies designed to improve patient outcomes and standards of care, end-to-end plasma collection technologies that optimize operations for plasma centers, and products that enable blood centers to collect needed blood components. For more information about Haemonetics, please visit .

Investor Contacts:     
Olga Guyette, Vice President-Investor Relations & Treasury     
(781) 356-9763   
 

David Trenk, Manager-Investor Relations
(203) 733-4987
                                                                               

Media Contact:       
Josh Gitelson, Sr. Director-Global Communications   
(781) 356-9776
 

SOURCE Haemonetics Corporation

“`